-$8.7M
Value of Insider Transactions in the last 2 years

Sign up to access historical data

Sign up

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
LINK WILLIAM J PHDAug 12, 2024Sell29,979$26.01$780,000
LINK WILLIAM J PHDAug 12, 2024Sell5,021$26.53$130,000
Farrow Jeffrey SJun 18, 2024Sell10,445$27.47$290,000
Azamian Bobak R.Mar 18, 2024Sell10,415$30.6$320,000
Mottiwala AzizMar 18, 2024Sell4,766$30.6$150,000
Wahl BryanMar 18, 2024Sell4,436$30.6$140,000
Whitfield Dianne C.Mar 18, 2024Sell4,314$30.6$130,000
Neervannan SeshadriMar 18, 2024Sell4,879$30.6$150,000
Azamian Bobak R.Dec 27, 2023Sell8,000$20.22$160,000
Azamian Bobak R.Dec 20, 2023Sell30,557$20.36$620,000
Azamian Bobak R.Dec 20, 2023Sell9,443$19.96$190,000
Trevejo Jose M.Dec 20, 2023Sell2,252$20$45,000
Goldberg Andrew D.Dec 15, 2023Buy1,000$18.96$19,000
Wahl BryanNov 30, 2023Sell8,356$16.31$140,000
Whitfield Dianne C.Nov 30, 2023Sell8,355$16.31$140,000
Azamian Bobak R.Nov 15, 2023Sell4,904$18.54$91,000
Azamian Bobak R.Nov 15, 2023Sell2,896$18.01$52,000
Azamian Bobak R.Nov 15, 2023Sell200$19.28$3,900
Azamian Bobak R.Oct 18, 2023Sell8,000$13.24$110,000
Trevejo Jose M.Oct 5, 2023Sell1,604$18$29,000
Azamian Bobak R.Sep 20, 2023Sell8,000$17.21$140,000
Azamian Bobak R.Aug 23, 2023Sell8,000$17.23$140,000
Lin Elizabeth YeuAug 15, 2023Buy9,506$16.8$160,000
Azamian Bobak R.Jul 19, 2023Sell99,726$20.04$2M
Azamian Bobak R.Jul 19, 2023Sell4,174$19.28$80,000
Mottiwala AzizJul 19, 2023Sell2,400$20.05$48,000
Azamian Bobak R.Jul 12, 2023Sell9,000$17.35$160,000
Azamian Bobak R.Jun 21, 2023Sell8,000$18.63$150,000
Azamian Bobak R.Jun 14, 2023Sell9,000$18.58$170,000
Azamian Bobak R.Jun 8, 2023Sell3,100$20.01$62,000
Mottiwala AzizJun 8, 2023Sell100$20$2,000
Mottiwala AzizJun 7, 2023Sell2,500$19.34$48,000
Mottiwala AzizJun 6, 2023Sell2,143$18.61$40,000
Azamian Bobak R.May 17, 2023Sell8,000$15.9$130,000
Azamian Bobak R.May 10, 2023Sell9,000$16.8$150,000
Azamian Bobak R.May 1, 2023Sell5,841$15.1$88,000
Azamian Bobak R.Apr 28, 2023Sell4,278$15.13$65,000
Azamian Bobak R.Apr 21, 2023Sell2,311$15.03$35,000
Greenstein Leonard M.Apr 20, 2023Sell5,000$14.02$70,000
Azamian Bobak R.Apr 19, 2023Sell8,000$13.6$110,000
Wahl BryanMar 23, 2023Sell371$12.15$4,500
Whitfield Dianne C.Mar 23, 2023Sell345$12.15$4,200
Azamian Bobak R.Mar 23, 2023Sell737$12.15$9,000
Neervannan SeshadriMar 23, 2023Sell390$12.15$4,700
Mottiwala AzizMar 23, 2023Sell372$12.15$4,500
Trevejo Jose M.Mar 23, 2023Sell465$12.15$5,600
Greenstein Leonard M.Mar 23, 2023Sell346$12.15$4,200
Wahl BryanMar 22, 2023Sell357$12.64$4,500
Whitfield Dianne C.Mar 22, 2023Sell333$12.64$4,200
Azamian Bobak R.Mar 22, 2023Sell709$12.64$9,000
Neervannan SeshadriMar 22, 2023Sell379$12.64$4,800
Mottiwala AzizMar 22, 2023Sell357$12.64$4,500
Trevejo Jose M.Mar 22, 2023Sell529$12.64$6,700
Greenstein Leonard M.Mar 22, 2023Sell332$12.64$4,200
Wahl BryanMar 21, 2023Sell350$12.89$4,500
Whitfield Dianne C.Mar 21, 2023Sell326$12.89$4,200
Azamian Bobak R.Mar 21, 2023Sell679$12.89$8,800
Neervannan SeshadriMar 21, 2023Sell372$12.89$4,800
Mottiwala AzizMar 21, 2023Sell349$12.89$4,500
Trevejo Jose M.Mar 21, 2023Sell519$12.89$6,700
Greenstein Leonard M.Mar 21, 2023Sell326$12.89$4,200
Wahl BryanMar 20, 2023Sell357$12.61$4,500
Whitfield Dianne C.Mar 20, 2023Sell333$12.61$4,200
Azamian Bobak R.Mar 20, 2023Sell741$12.61$9,300
Neervannan SeshadriMar 20, 2023Sell380$12.61$4,800
Holdbrook Mark J.Mar 20, 2023Sell198$12.61$2,500
Mottiwala AzizMar 20, 2023Sell358$12.61$4,500
Trevejo Jose M.Mar 20, 2023Sell530$12.61$6,700
Greenstein Leonard M.Mar 20, 2023Sell333$12.61$4,200
Wahl BryanMar 17, 2023Sell339$13.28$4,500
Whitfield Dianne C.Mar 17, 2023Sell316$13.28$4,200
Azamian Bobak R.Mar 17, 2023Sell795$13.28$11,000
Neervannan SeshadriMar 17, 2023Sell360$13.28$4,800
Holdbrook Mark J.Mar 17, 2023Sell188$13.28$2,500
Mottiwala AzizMar 17, 2023Sell339$13.28$4,500
Trevejo Jose M.Mar 17, 2023Sell504$13.28$6,700
Greenstein Leonard M.Mar 17, 2023Sell316$13.28$4,200
Greenstein Leonard M.Mar 16, 2023Sell5,000$13.44$67,000
Azamian Bobak R.Mar 16, 2023Sell791$13.43$11,000
Greenstein Leonard M.Mar 16, 2023Sell313$13.43$4,200
Holdbrook Mark J.Mar 16, 2023Sell187$13.43$2,500
Wahl BryanMar 16, 2023Sell337$13.43$4,500
Whitfield Dianne C.Mar 16, 2023Sell313$13.43$4,200
Trevejo Jose M.Mar 16, 2023Sell499$13.43$6,700
Mottiwala AzizMar 16, 2023Sell336$13.43$4,500
Neervannan SeshadriMar 16, 2023Sell357$13.43$4,800
Azamian Bobak R.Mar 15, 2023Sell8,000$13.79$110,000
Azamian Bobak R.Mar 9, 2023Sell717$15.01$11,000
Azamian Bobak R.Mar 8, 2023Sell4,853$15.02$73,000
Greenstein Leonard M.Feb 16, 2023Sell5,000$15.12$76,000
Azamian Bobak R.Feb 15, 2023Sell8,000$15.28$120,000
Azamian Bobak R.Feb 8, 2023Sell9,000$15.14$140,000
Azamian Bobak R.Jan 23, 2023Sell4,856$15.45$75,000
Azamian Bobak R.Jan 20, 2023Sell240$15$3,600
Greenstein Leonard M.Jan 19, 2023Sell5,000$14.56$73,000
Azamian Bobak R.Jan 18, 2023Sell8,000$14.56$120,000
Azamian Bobak R.Jan 11, 2023Sell3,904$15.11$59,000
Azamian Bobak R.Jan 10, 2023Sell905$15.17$14,000
Azamian Bobak R.Jan 9, 2023Sell729$15.15$11,000
Azamian Bobak R.Jan 6, 2023Sell411$15$6,200
Azamian Bobak R.Dec 21, 2022Sell8,000$14.57$120,000
Azamian Bobak R.Dec 16, 2022Sell535$15.01$8,000
Greenstein Leonard M.Dec 15, 2022Sell5,000$14.64$73,000
Azamian Bobak R.Dec 14, 2022Sell6,420$15.08$97,000
Wahl BryanDec 2, 2022Sell1,154$16.9$20,000
Whitfield Dianne C.Dec 2, 2022Sell1,154$16.9$20,000
Wahl BryanDec 1, 2022Sell1,164$16.75$19,000
Whitfield Dianne C.Dec 1, 2022Sell1,165$16.75$20,000
Wahl BryanNov 30, 2022Sell1,183$16.5$20,000
Whitfield Dianne C.Nov 30, 2022Sell1,182$16.5$20,000

What's the latest insider transaction for Tarsus Pharmaceuticals?

The most recent insider transaction for Tarsus Pharmaceuticals was conducted by LINK WILLIAM J PHD, who sold 29,979 shares on August 12, 2024 at a price of $26.01 per share.

Which insider bought the most TARS stock over the last two years?

Lin Elizabeth Yeu has bought the most TARS stock in the last 2 years, with a total value of $160,000.

Which insider has sold the most TARS stock over the last two years?

Azamian Bobak R. has sold the most TARS stock in the last 2 years, with a total value of $6M.

What is the total value of insider transactions for Tarsus Pharmaceuticals (TARS) in the last 2 years?

The total value of insider transactions for Tarsus Pharmaceuticals in the last 2 years is negative, amounting to -$8.7M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

How do insider transactions over the last 2 years reflect on Tarsus Pharmaceuticals' market confidence?

Over the last 2 years, insider transactions for Tarsus Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Why is monitoring insider trading activity important for investors?

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.